CN105380921A - 一种氢溴酸沃替西汀片的制备方法 - Google Patents
一种氢溴酸沃替西汀片的制备方法 Download PDFInfo
- Publication number
- CN105380921A CN105380921A CN201510936699.7A CN201510936699A CN105380921A CN 105380921 A CN105380921 A CN 105380921A CN 201510936699 A CN201510936699 A CN 201510936699A CN 105380921 A CN105380921 A CN 105380921A
- Authority
- CN
- China
- Prior art keywords
- preparation
- hydrobromic acid
- irrigates
- acid according
- western spit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510936699.7A CN105380921B (zh) | 2015-12-15 | 2015-12-15 | 一种氢溴酸沃替西汀片的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510936699.7A CN105380921B (zh) | 2015-12-15 | 2015-12-15 | 一种氢溴酸沃替西汀片的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105380921A true CN105380921A (zh) | 2016-03-09 |
CN105380921B CN105380921B (zh) | 2017-06-09 |
Family
ID=55414103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510936699.7A Active CN105380921B (zh) | 2015-12-15 | 2015-12-15 | 一种氢溴酸沃替西汀片的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105380921B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106667941A (zh) * | 2017-02-23 | 2017-05-17 | 佛山市弘泰药物研发有限公司 | 一种沃替西汀口崩片及其制备方法 |
CN107412183A (zh) * | 2017-04-17 | 2017-12-01 | 深圳市泛谷药业股份有限公司 | 一种氢溴酸沃替西汀片及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1839835A (zh) * | 2005-03-31 | 2006-10-04 | 北京德众万全医药科技有限公司 | 一种拉西地平药物制剂的制备方法 |
CN104119298A (zh) * | 2014-08-13 | 2014-10-29 | 北京蓝贝望生物医药科技股份有限公司 | 氢溴酸沃赛汀或氢溴酸沃替西汀 |
CN104644594A (zh) * | 2015-02-03 | 2015-05-27 | 郑州大明药物科技有限公司 | 一种氢溴酸沃替西汀胃溶片及其制备方法 |
CN105111167A (zh) * | 2015-08-06 | 2015-12-02 | 华南理工大学 | 一种沃替西汀半盐酸盐及其制备方法和药物组合物 |
-
2015
- 2015-12-15 CN CN201510936699.7A patent/CN105380921B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1839835A (zh) * | 2005-03-31 | 2006-10-04 | 北京德众万全医药科技有限公司 | 一种拉西地平药物制剂的制备方法 |
CN104119298A (zh) * | 2014-08-13 | 2014-10-29 | 北京蓝贝望生物医药科技股份有限公司 | 氢溴酸沃赛汀或氢溴酸沃替西汀 |
CN104644594A (zh) * | 2015-02-03 | 2015-05-27 | 郑州大明药物科技有限公司 | 一种氢溴酸沃替西汀胃溶片及其制备方法 |
CN105111167A (zh) * | 2015-08-06 | 2015-12-02 | 华南理工大学 | 一种沃替西汀半盐酸盐及其制备方法和药物组合物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106667941A (zh) * | 2017-02-23 | 2017-05-17 | 佛山市弘泰药物研发有限公司 | 一种沃替西汀口崩片及其制备方法 |
CN107412183A (zh) * | 2017-04-17 | 2017-12-01 | 深圳市泛谷药业股份有限公司 | 一种氢溴酸沃替西汀片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105380921B (zh) | 2017-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103083278A (zh) | 一种罗红霉素胶囊及其制备方法 | |
CN104337790A (zh) | 盐酸鲁拉西酮口服制剂及其制备方法 | |
CN105412026B (zh) | 盐酸阿考替胺片及其制备方法 | |
CN105380921A (zh) | 一种氢溴酸沃替西汀片的制备方法 | |
CN104983732A (zh) | 一种布洛肾素那敏片及其制备方法 | |
CN104523615B (zh) | 一种舒必利片及其制备方法 | |
CN105055354A (zh) | 一种利奈唑胺片及其制备方法 | |
CN101069742B (zh) | 一种胰激肽原酶片剂及其制备方法 | |
CN103083273A (zh) | 甲磺酸伊马替尼片芯、包衣片及其制备方法 | |
CN101125131A (zh) | 一种氟哌噻吨美利曲辛胶囊的制备方法 | |
CN103127022A (zh) | 一种别嘌醇复合型释药系统及其制备方法 | |
CN114767648A (zh) | 一种依西美坦薄膜衣片及其制备方法 | |
CN107233325A (zh) | 一种含伊马替尼的组合物及其制备方法 | |
CN114129524A (zh) | 对乙酰氨基酚片剂及其制备方法 | |
CN107684549A (zh) | 一种缬沙坦片剂及其制备方法 | |
CN109498584A (zh) | 一种含有来曲唑的分散片及其新型制备方法 | |
CN105640908A (zh) | 一种盐酸米那普仑缓释片及其制备方法 | |
CN109730969A (zh) | 一种乳酸左氧氟沙星分散片及其制备方法 | |
CN111450074A (zh) | 一种吗替麦考酚酯胶囊及其制备方法 | |
CN102846579B (zh) | 一种缬沙坦药用胶囊及其制备方法 | |
CN103520125B (zh) | 一种替米沙坦组合物 | |
CN103550180B (zh) | 一种达沙替尼片及其制备工艺 | |
CN111374953A (zh) | 对乙酰氨基酚片及其制备工艺 | |
CN113768889B (zh) | 一种含西洛他唑的药物组合物及其制备方法 | |
CN114053235B (zh) | 茶碱缓释片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 528451 Guangdong province Zhongshan Nanlang town of Southern China modern Chinese Medicine City Branch Chong Park No. 2 Applicant after: Zhongshan Wan Han Pharmaceutical Co., Ltd. Address before: 528449 Guangdong province Zhongshan Nanlang town of Southern China modern Chinese Medicine City Branch Chong Park No. 2 Applicant before: Zhong Shanwanhan Pharmaceutical Technology Co., Ltd |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zheng Mingze Inventor after: Du Zhibo Inventor after: Wang Heran Inventor after: Peng Wei Inventor after: Zhou Fenhe Inventor before: Peng Wei Inventor before: Zheng Mingze Inventor before: Zhou Fenhe |
|
CB03 | Change of inventor or designer information |